LVAD patient: Which condition should you suspect?

LVAD patient: Which condition should you suspect?

• A. Acute myocardial infarction
• B. Obstructive lung disease
• C. Uncontrolled hypertension
• D. Thoracic aortic aneurysm

Answer: (A)

When someone has an LVAD, the device helps the left ventricle pump blood, but it doesn’t eliminate the risk of ischemic heart disease. An acute myocardial infarction is a critical event to suspect because many LVAD patients already have significant coronary disease, and an ischemic event can still occur and precipitate instability or chest pain, even if the device is maintaining overall forward flow. Ischemia in these patients can be masked by the LVAD’s support, so clinicians must vigilantly look for signs of MI—new chest pain, dyspnea, hypotension or arrhythmias, and objective findings such as ECG changes and rising cardiac biomarkers. Rapid evaluation with ECG, troponins, and device interrogation, along with appropriate cardiology input, is essential to address an MI in this context. The other options don’t fit as well because obstructive lung disease would not typically present as an acute, life-threatening cardiac event in an LVAD patient, uncontrolled hypertension is possible but not the most immediate concern driving urgent assessment, and thoracic aortic aneurysm presents differently (often with tearing chest pain or different clinical signs). The scenario centers on recognizing an ischemic event as a key, high-risk issue in LVAD patients.

When someone has an LVAD, the device helps the left ventricle pump blood, but it doesn’t eliminate the risk of ischemic heart disease. An acute myocardial infarction is a critical event to suspect because many LVAD patients already have significant coronary disease, and an ischemic event can still occur and precipitate instability or chest pain, even if the device is maintaining overall forward flow. Ischemia in these patients can be masked by the LVAD’s support, so clinicians must vigilantly look for signs of MI—new chest pain, dyspnea, hypotension or arrhythmias, and objective findings such as ECG changes and rising cardiac biomarkers. Rapid evaluation with ECG, troponins, and device interrogation, along with appropriate cardiology input, is essential to address an MI in this context.

The other options don’t fit as well because obstructive lung disease would not typically present as an acute, life-threatening cardiac event in an LVAD patient, uncontrolled hypertension is possible but not the most immediate concern driving urgent assessment, and thoracic aortic aneurysm presents differently (often with tearing chest pain or different clinical signs). The scenario centers on recognizing an ischemic event as a key, high-risk issue in LVAD patients.